Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 4
1947 8
1948 10
1949 5
1950 3
1951 8
1952 12
1953 8
1954 5
1955 11
1956 5
1957 6
1958 4
1959 10
1960 9
1961 2
1962 9
1963 10
1964 27
1965 10
1966 16
1967 17
1968 34
1969 31
1970 27
1971 48
1972 36
1973 45
1974 56
1975 45
1976 42
1977 38
1978 41
1979 58
1980 60
1981 51
1982 65
1983 67
1984 96
1985 115
1986 117
1987 104
1988 101
1989 146
1990 132
1991 135
1992 124
1993 171
1994 171
1995 189
1996 202
1997 249
1998 243
1999 264
2000 273
2001 332
2002 348
2003 355
2004 440
2005 446
2006 535
2007 575
2008 571
2009 622
2010 736
2011 783
2012 919
2013 986
2014 1024
2015 962
2016 986
2017 1051
2018 1010
2019 1035
2020 1259
2021 1355
2022 1362
2023 1290
2024 419

Text availability

Article attribute

Article type

Publication date

Search Results

20,771 results

Results by year

Filters applied: . Clear all
Page 1
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Cervantes A, Adam R, Roselló S, Arnold D, Normanno N, Taïeb J, Seligmann J, De Baere T, Osterlund P, Yoshino T, Martinelli E; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Cervantes A, et al. Ann Oncol. 2023 Jan;34(1):10-32. doi: 10.1016/j.annonc.2022.10.003. Epub 2022 Oct 25. Ann Oncol. 2023. PMID: 36307056 Free article. No abstract available.
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G, Vogel A, Smyth EC; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Lordick F, et al. Ann Oncol. 2022 Oct;33(10):1005-1020. doi: 10.1016/j.annonc.2022.07.004. Epub 2022 Jul 29. Ann Oncol. 2022. PMID: 35914639 Free article. No abstract available.
Current clinical management of gastrointestinal stromal tumor.
Akahoshi K, Oya M, Koga T, Shiratsuchi Y. Akahoshi K, et al. World J Gastroenterol. 2018 Jul 14;24(26):2806-2817. doi: 10.3748/wjg.v24.i26.2806. World J Gastroenterol. 2018. PMID: 30018476 Free PMC article. Review.
Gastrointestinal stromal tumors (GISTs) are the most common malignant subepithelial lesions (SELs) of the gastrointestinal tract. ...However, a GIST is usually detected as a SEL during endoscopy, and many benign and malignant conditions m …
Gastrointestinal stromal tumors (GISTs) are the most common malignant subepithelial lesions (SELs) of the gastrointe …
ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.
Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW; American College of Gastroenterology. Syngal S, et al. Am J Gastroenterol. 2015 Feb;110(2):223-62; quiz 263. doi: 10.1038/ajg.2014.435. Epub 2015 Feb 3. Am J Gastroenterol. 2015. PMID: 25645574 Free PMC article. Review.
This guideline presents recommendations for the management of patients with hereditary gastrointestinal cancer syndromes. The initial assessment is the collection of a family history of cancers and premalignant gastrointestinal conditions and should provide enough i …
This guideline presents recommendations for the management of patients with hereditary gastrointestinal cancer syndromes. The initial …
Artificial Intelligence in Colorectal Cancer Screening, Diagnosis and Treatment. A New Era.
Mitsala A, Tsalikidis C, Pitiakoudis M, Simopoulos C, Tsaroucha AK. Mitsala A, et al. Curr Oncol. 2021 Apr 23;28(3):1581-1607. doi: 10.3390/curroncol28030149. Curr Oncol. 2021. PMID: 33922402 Free PMC article. Review.
We also explore the role of recent advances in AI systems regarding medical diagnosis and therapy, with several promising results. CRC is a highly preventable disease, and AI-assisted techniques in routine screening represent a pivotal step in declining incidence rates of …
We also explore the role of recent advances in AI systems regarding medical diagnosis and therapy, with several promising results. CR …
ACG Clinical Guideline: Diagnosis and Management of Gastrointestinal Subepithelial Lesions.
Jacobson BC, Bhatt A, Greer KB, Lee LS, Park WG, Sauer BG, Shami VM. Jacobson BC, et al. Am J Gastroenterol. 2023 Jan 1;118(1):46-58. doi: 10.14309/ajg.0000000000002100. Epub 2022 Sep 6. Am J Gastroenterol. 2023. PMID: 36602835
Subepithelial lesions (SEL) of the GI tract represent a mix of benign and potentially malignant entities including tumors, cysts, or extraluminal structures causing extrinsic compression of the gastrointestinal wall. ...There is insufficient evidence t …
Subepithelial lesions (SEL) of the GI tract represent a mix of benign and potentially malignant entities including tumors …
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Obermannová R, Alsina M, Cervantes A, Leong T, Lordick F, Nilsson M, van Grieken NCT, Vogel A, Smyth EC; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Obermannová R, et al. Ann Oncol. 2022 Oct;33(10):992-1004. doi: 10.1016/j.annonc.2022.07.003. Epub 2022 Jul 29. Ann Oncol. 2022. PMID: 35914638 Free article. No abstract available.
Management of pain in colorectal cancer patients.
Zielińska A, Włodarczyk M, Makaro A, Sałaga M, Fichna J. Zielińska A, et al. Crit Rev Oncol Hematol. 2021 Jan;157:103122. doi: 10.1016/j.critrevonc.2020.103122. Epub 2020 Oct 19. Crit Rev Oncol Hematol. 2021. PMID: 33171427 Review.
Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance.
Gallo C, Rossi RE, Cavalcoli F, Barbaro F, Boškoski I, Invernizzi P, Massironi S. Gallo C, et al. World J Gastroenterol. 2022 Mar 21;28(11):1123-1138. doi: 10.3748/wjg.v28.i11.1123. World J Gastroenterol. 2022. PMID: 35431507 Free PMC article. Review.
Rectal neuroendocrine neoplasms (r-NENs) are considered among the most frequent digestive NENs, together with small bowel NENs. ...R-NENs larger than 20 mm are candidates for surgical resection because of their high risk of distant spreading and the involvement of the musc …
Rectal neuroendocrine neoplasms (r-NENs) are considered among the most frequent digestive NENs, together with small bowel NENs. ...R- …
20,771 results
You have reached the last available page of results. Please see the User Guide for more information.